Clicky

PMV Pharmaceuticals, Inc.(PMVP)

Description: PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.


Keywords: Cancer Biology Cell Biology Proteins Apoptosis P53 Tumor Suppressor Genes Programmed Cell Death

Home Page: www.pmvpharma.com

PMVP Technical Analysis

8 Clarke Drive
Cranbury, NJ 08512
United States
Phone: 609 642 6670


Officers

Name Title
Dr. David H. Mack Ph.D. Co-Founder, CEO, Pres & Director
Dr. Arnold J. Levine Ph.D. Co-Founder, Independent Director & Member of Scientific Advisory Board
Mr. Winston Kung M.B.A. COO & CFO
Dr. Deepika Jalota Pharm.D. Chief Regulatory & Quality Assurance Officer
Dr. Leila Alland M.D. Chief Medical Officer
Dr. Thomas E. Shenk Ph.D. Co-Founder & Member of Scientific Advisory Board
Mr. Robert Ticktin Gen. Counsel & Company Sec.
Mr. Tim Smith Sr. VP & Head of Corp. Devel.
Dr. Binh Vu Ph.D. Sr. VP of Drug Discovery & CMC

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.6976
Price-to-Sales TTM: 0
IPO Date: 2020-09-25
Fiscal Year End: December
Full Time Employees: 54
Back to stocks